Letter to Editor on CRISPR-Cas9 genome editing and Nobel Prize

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Aurum Journal of Health Sciences
Volume:3 Issue:1
Letter to Editor on CRISPR-Cas9 genome editing and Nobel Prize

Letter to Editor on CRISPR-Cas9 genome editing and Nobel Prize

Authors : Eriona HETA

Pages : 1-2

View : 63 | Download : 9

Publication Date : 2021-01-31

Article Type : Other Papers

Abstract :The countless applications of CRISPR-Cas9 genetic scissors are benefiting all of us in our research centres and we will most probably continue to benefit from this technology in the future. However, there are still questions that need to be answered: what will happen with the human genome editing in the long run? When will genome editing be proven to be safe and efficient to be used in editing human embryos? How many more experiments are necessary to be done on embryos to get an answer? Are there going to be rules and authorization in using gene-therapy kits in human genome editing, to prevent misuse of the technology? When will CRISPR-based gene editing be routinely used in clinic? We still need more time to get an answer to these questions and learn more about this technology. Let’s see together what surprising outcomes will genome editing science CRISPR-Cas9 bring us.
Keywords : CRISPR Cas9, genome editing, Nobel Prize

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.